Projektbeschreibung
Nachahmung von lebenden Systemen im Mikrobereich
Lebende Systeme wie Gewebe, Organe und Organellen führen in Kompartimenten spezifische biologische Prozesse aus, um eine höhere Effizienz zu erreichen. Wenn es gelingt, diese Vorgänge künstlich nachzuahmen, könnten sich dadurch neue Möglichkeiten für technologische Fortschritte in der Biomedizin auftun. Das EU-finanzierte Projekt ACDC wird sich die Lab-on-a-Chip-Technologie und Mikrofluidik zur Entwicklung einer funktionalen Plattform zunutze machen, die sich für die Theranostik oder Umweltanwendungen programmieren und konfigurieren lässt. Bei der Erzeugung reaktionsfähiger Architekturen werden sich die Forschenden an der Hierarchie von lebenden Systemen orientieren. Die daraus hervorgehenden Kapseln werden in der Lage sein, bei der Ausführung von biochemischen oder chemischen Reaktionen wie Mikrolabore untereinander zu kommunizieren.
Ziel
We envision a future where ‘chemical apps’ on mobile devices produce on demand valuable compounds for health and performance as well as apps for bioagent threat detection and disease. To take concrete and defined steps toward this future vision, we will exploit the miniaturization provided by lab on a chip technology and construct responsive architectures and metabolism based on living cells and tissues. We will build programmable and re-configurable, (bio)chemical processes, with precision, order, and as hierarchical cellular constructs, in the same way as living systems. We will enable microscale, liquid-based, chemical compartmentalisation (cores), and inter-compartmental (core-core) communication, just as one finds in organelles, cells and tissues. ACDC will focus on developing this next generation technology through a detailed workplan that heavily involves the nontrivial tasks of integrating diverse state of the art technologies including microfluidics, microwave resonators, DNA-based supramolecular assembly, in vitro gene expression and the integration of membrane channels into a functional platform. In a future embodiment of this project, artificial cell technology will be used as programmable and reconfigurable matter for specific applications, including theranostics and personalized medicine as well as sensing and actuation in the environments for bioremediation.
As the first steps towards that future vision, we aim to produce an artificial technological construct and process that recapitulates some aspects of living systems on the microscale, and therefore this project will produce exemplars of secondary living technologies concentrating on the wetware class [1] but also a multi-level mathematical framework. We have assembled an international, interdisciplinary team from academia, industry and public engagement. Our outreach and engagement programme will define the impact in both the public and economic sectors with ethical dimensions considered. Further, building upon 55 years of collective start-up enterprise experience, we will explore the translation of new intellectual property generated into commercial advantage and job creation for the European Union.
Wissenschaftliches Gebiet
- natural sciencesphysical sciencesclassical mechanicsfluid mechanicsmicrofluidics
- engineering and technologyenvironmental biotechnologybioremediation
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- medical and health scienceshealth sciencespersonalized medicine
- medical and health sciencesmedical biotechnologycells technologies
Schlüsselbegriffe
Programm/Programme
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-FETPROACT-2018-01
Finanzierungsplan
RIA - Research and Innovation actionKoordinator
38122 Trento
Italien